Truist Starts Coverage on Accenture (ACN) With $317 Price Target

Analysts judge that ACN’s concern premix should enactment mid-single-digit maturation and unchangeable margins implicit a multi-year clip horizon. This is contempt existent banal valuation pricing successful concerns astir existing concern being cannibalized by GenAI.

"The banal trades astatine a worldly discount to its humanities mean mostly owed to GenAI cannibalization of existing business. We deliberation diligent investors volition beryllium rewarded fixed ACN's strategical partnerships with the starring frontier labs, broader GenAI ecosystem, and track-record successful cannibalizing bequest revenue.” -Ramnani and his team.

Neverthless, strategical partnerships with starring frontier labs and the broader GenAI ecosystem service arsenic affirmative factors for the company. Accenture besides holds a way grounds for successfully cannibalizing bequest gross streams, which is an denotation that diligent investors would apt beryllium rewarded implicit time.

Accenture plc (NYSE:ACN) offers strategy and consulting services.

While we admit the imaginable of ACN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 11 AI Stocks connected the Market’s Radar and 10 AI Stocks Analysts Are Watching Closely

Disclosure: None.